Orthobiologics materials are made from substances naturally found in the human body. Usages of these substances help to cure injuries rapidly. Hence orthobiologics are extensively used in surgeries and treatments of osteoarthritis & degenerative arthritis, spinal fusion, fracture recovery, soft tissue injuries, and to treat other bone-related injuries such as the broken bones along with injured muscles, tendons, and ligaments.
In addition, to a speedy recovery, using orthobiologics in conservative therapies ensures the lesser impact of degenerative disease. Moreover, orthobiologic procedures can be completed in OPDs (Outpatient Department), and recovery is faster than surgery. Besides, a larger part of orthobiologic treatments is covered by insurance. As a result, the global orthobiologics market garners tremendous traction worldwide.
Get Request Free Sample @ https://www.marketresearchfuture.com/sample_request/7826
Moreover, the massive consumption of orthobiologics in the healthcare sector for a range of medical applications and rising awareness towards the benefits of these materials accelerate market growth. According to a leading research firm - Market Research Future (MRFR), the global orthobiologics market is projected to reach USD 4,964 MN by the end of 2019. MRFR, in its recently publishes study report, also asserts that the market would register around 6.7 % CAGR during the forecast period (2019–2024).
Additionally, factors such as the increasing investments in R&D to drive product development activities are propelling the growth of the market. Also, the demand for minimally invasive procedures for the treatments of increasing cases of trauma and sports injuries would help the market to witness spurting growth throughout the review period. Moreover, emerging technological innovations in biomaterials and rising prevalence of various disorders related to bones and the overweight and geriatric population create enormous market demand.
On the other hand, poor reimbursement policies and lack of awareness among people about the advantages of these materials are likely to impede the market growth during the assessment period. Also, the prohibitive cost of orthobiologics affects market growth negatively. Nevertheless, improving economic conditions would support market growth, enabling access to improved healthcare.
Global Orthobiologics Market - Segmentations
The global orthobiologics market has been segmented on the basis of product, application, end-user, and region.
Based on product, the market has been classified as a Demineralized bone matrix (DBM), Bone morphogenetic protein (BPM), Allograft, Viscosupplementation products, Synthetic bone substitutes, and Others.
Global orthobiologics market on the basis of application has been segmented into Osteoarthritis & degenerative arthritis, Spinal fusion, Fracture recovery, Soft tissue injuries, and Others.
Based on end-user, the market has been segmented into Hospitals, Orthopedic Clinics, and Others.
Global Orthobiologics Market - Geographical Analysis
North America dominates the global orthobiologics market, owing to the technological advancements, increasing funding & investments, and rising prevalence of bone injuries caused due to accidents. Heading with favorable government regulations that are growing integration for orthobiologics, the region is would retain its leading position throughout the assessment period.
Simultaneously, rising numbers of orthopedic surgeries, alongside, the increasing geriatric populace, boost the growth of the regional market, leading to an increase in the patient population. Furthermore, increasing awareness among people and the rising demand for technologically advanced treatments and products enhances the growth of the regional market.
Europe stands second in the global orthobiologics market. Factors such as the increased research & development activities in the field backed by government support and funds, attribute to the regional market growth. The availability of innovative treatment facilities alongside, the rising research initiatives in the field of orthopedic biomaterials is fostering the market growth in the region. Moreover, increasing orthopedic surgeries with growing awareness among populations regarding healthcare.
The orthobiologics market in the Asia Pacific region is rapidly emerging as a promising market globally. Continually rising population and the burgeoning medical treatment market in the region attribute to the regional market growth. Growing markets in India and China backed by the increasing awareness & improved healthcare services provide impetus to the market growth. Besides, the improved economy in the region drives the growth of the orthobiologics market, colossally, creating various growth opportunities.
Global Orthobiologics Market - Competitive Landscape
Highly competitive, the orthobiologics market appears to be fragmented due to the presence of several well-established players. Moreover, the market attracts several new entrants, demonstrating attractive growth opportunities. This, as a result, intensifies the competition in the market, further. Manufacturers strive to develop innovative materials, utilizing advanced technologies and best practices.
To gain a substantial share in the market, players incorporate strategies such as mergers & acquisitions, collaboration, and expansion. They make substantial investments in R&D for product development and improvements. Expansions and superior product development help them in increasing sales, production capacities, and potential to fetch larger turnovers at a much-reduced logistic cost.
Major Players:
Players leading the global orthobiologics market include Exactech, Inc., Arthrex, Inc., Globus Medical Inc., Johnson & Johnson, Integra LifeSciences, Medline Industries, Inc., Stryker Corporation, NuVasive, Inc., Wright Medical Group NV, and Zimmer Biomet, among others.
Industry/ Innovation /Related News:
September 25, 2019 --- Bioventus LLC (the US), a global leader in the science & application of orthobiologics, announced signing a nationwide contract with UnitedHealthcare Employer (UHC – the US), a healthcare insurance company to provide them with the access to its DUROLANE and GELSYN-3 treatments for osteoarthritis (OA) knee pain. These products promote healing in the treatment of osteoarthritis and surgical and non-surgical bone healing.
Starting from October 1, 2019, UHC commercial plan members will have access to these safe HA products, proven to provide relief from knee OA pain management. This includes the production and marketing of ultrasound bone growth stimulators.
Ref:
https://ryortho.com/breaking/bioventus-announces-partnership-with-unitedhealthcare/
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
Chapter 3. Research Methodology
3.1. Introduction
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
Chapter 4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities
4.4. Challenges
4.5. Macroeconomic Indicators
Chapter 5. Market Factor Analysis
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.3. Investment Feasibility Analysis
Browse Complete Report @ https://www.marketresearchfuture.com/reports/negative-pressure-wound-therapy-market-6514
Related reports link:-
Mouth Ulcer Treatment Market
4D Printing in Healthcare Market
Hyperhidrosis Treatment Market
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
